bioAffinity Technologies, Inc. (BIAF)

USD 1.04

(1.96%)

Market Cap (In USD)

16.2 Million

Revenue (In USD)

2.53 Million

Net Income (In USD)

-7.93 Million

Avg. Volume

115.83 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.831-3.62
PE
-
EPS
-
Beta Value
3.124
ISIN
US09076W1099
CUSIP
09076W109
CIK
1712762
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Ms. Maria Zannes J.D.
Employee Count
-
Website
https://www.bioaffinitytech.com
Ipo Date
2022-09-01
Details
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.